Related Experiment Video
Updated: Sep 27, 2026

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
Published on: May 2, 2025
A new platelet parameter, the mean platelet component, can demonstrate abnormal platelet function and structure in
D R Brummitt1, H F Barker, N Pujol-Moix
1Department of Haematology, Rotherham General Hospitals NHS Trust, Rotherham, S60 2UD, UK.
Abstract:
The mean platelet component (MPC) is a new platelet parameter generated by the Bayer ADVIA 120 full blood count analyser as part of the routine complete blood count (CBC) test cycle. We report a case of myelodysplasia with bleeding complications and abnormal template bleeding time in whom low mean platelet component parameters were associated with partial platelet granule deficiency, demonstrated by transmission electron microscopy. We suggest that the mean platelet component is an inexpensive and rapid test to screen for platelet dysfunction related to ultrastructural abnormalities in myelodysplasia.
Insights
Low mean platelet component (MPC) levels may indicate platelet dysfunction in myelodysplasia patients. This inexpensive test can help screen for ultrastructural abnormalities, aiding in diagnosing bleeding complications.
Area of Science:
- Hematology
- Clinical Pathology
Background:
- The mean platelet component (MPC) is a novel parameter from the Bayer ADVIA 120 analyser.
- Complete blood count (CBC) analysis routinely includes MPC.
- Myelodysplasia can present with bleeding issues and abnormal bleeding times.
Observation:
- A case study involving myelodysplasia with bleeding complications and abnormal bleeding time was analyzed.
- Low MPC parameters were observed in the patient.
- Transmission electron microscopy revealed partial platelet granule deficiency.
Findings:
- Low MPC values correlated with partial platelet granule deficiency in the myelodysplasia case.
- This suggests a link between MPC and platelet ultrastructure.
Implications:
- Mean platelet component (MPC) may serve as a cost-effective and rapid screening tool for platelet dysfunction.
- It can identify patients with myelodysplasia and potential ultrastructural platelet abnormalities.
- This aids in managing bleeding complications associated with myelodysplasia.

